Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Phase II Study of the Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions in Patients With Advanced Hepatocellular Carcinoma

NCT01934829 is registered in ClinicalTrials.gov with Chinese Anti-Cancer Association as lead sponsor.

NCT NCT01934829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01934829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Phase II Study of the Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions in Patients With Advanced Hepatocellular Carcinoma
Lead sponsor
Chinese Anti-Cancer Association
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
July 31, 2010
Enrollment
871 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma